Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
2.78%
↑ 131% vs avg
Percentile
P41
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
-9.01%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 2.78% |
| Q3 2025 | 15.52% |
| Q2 2025 | 26.77% |
| Q1 2025 | -19.30% |
| Q4 2024 | -79.83% |
| Q3 2024 | 52.34% |
| Q2 2024 | 24.82% |
| Q1 2024 | -72.70% |
| Q4 2023 | -13.56% |
| Q3 2023 | 14.36% |
| Q2 2023 | 48.95% |
| Q1 2023 | -26.72% |
| Q4 2022 | -61.78% |
| Q3 2022 | 21.02% |
| Q2 2022 | 10.28% |
| Q1 2022 | -22.55% |
| Q4 2021 | 8.63% |
| Q3 2021 | -8.90% |
| Q2 2021 | 41.98% |
| Q1 2021 | -43.25% |
| Q4 2020 | -58.24% |
| Q3 2020 | -178.13% |
| Q2 2020 | 206.18% |
| Q1 2020 | -0.50% |
| Q4 2019 | 5.32% |
| Q3 2019 | 5.55% |
| Q2 2019 | 13.98% |
| Q1 2019 | -80.33% |
| Q4 2018 | 36.08% |
| Q3 2018 | 19.13% |
| Q2 2018 | 6.56% |
| Q1 2018 | -58.67% |
| Q4 2017 | -198.67% |
| Q3 2017 | 75.79% |
| Q2 2017 | 45.59% |
| Q1 2017 | -198.86% |
| Q4 2016 | 40.95% |
| Q3 2016 | 12.69% |
| Q2 2016 | 18.45% |
| Q1 2016 | 8.01% |